Middle East & Africa Sepsis Diagnostics Market

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028

Analysis – by Product (Instruments, Reagents and Assays, Blood Culture Media, and Software), Technology (Molecular Diagnostics {Polymerase Chain Reaction, Peptide Nucleic Acid-Fluorescent in Situ Hybridization, Syndromic Panel-Based Testing, Microarrays}, Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, and Microbiology), Method (Automated Diagnostics and Conventional Diagnostics), Test Type (Point-of-Care Tests and Laboratory Tests), Pathogen (Bacterial Sepsis, Fungal Sepsis, and Others), and End User (Hospitals, Pathology and Reference Laboratories, and Others)

No. of Pages: 205
Report Code: BMIRE00025662
Category: Life Sciences
Middle East & Africa Sepsis Diagnostics Market
Free Sample Buy Now

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. Middle East & Africa Sepsis Diagnostics Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. Middle East & Africa Sepsis Diagnostics Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. Middle East & Africa Sepsis Diagnostics Market Regional Analysis

6.2 Middle East & Africa Sepsis Diagnostics Market Revenue 2019-2028 (US$ Million)
6.3 Middle East & Africa Sepsis Diagnostics Market Forecast Analysis

7. Middle East & Africa Sepsis Diagnostics Market Analysis – by Product

7.1 Instruments
  • 7.1.1 Overview
  • 7.1.2 Instruments: Middle East & Africa Sepsis Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Reagents and Assays
  • 7.2.1 Overview
  • 7.2.2 Reagents and Assays: Middle East & Africa Sepsis Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.3 Blood Culture Media
  • 7.3.1 Overview
  • 7.3.2 Blood Culture Media: Middle East & Africa Sepsis Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.4 Software
  • 7.4.1 Overview
  • 7.4.2 Software: Middle East & Africa Sepsis Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. Middle East & Africa Sepsis Diagnostics Market Analysis – by Technology

8.1 Molecular Diagnostics
  • 8.1.1 Overview
  • 8.1.2 Molecular Diagnostics : Middle East & Africa Sepsis Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. Middle East & Africa Sepsis Diagnostics Market Analysis – by Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, Microbiology)

9. Middle East & Africa Sepsis Diagnostics Market Analysis – by Method

9.1 Automated Diagnostics and Conventional Diagnostics
  • 9.1.1 Overview
  • 9.1.2 Automated Diagnostics and Conventional Diagnostics: Middle East & Africa Sepsis Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

10. Middle East & Africa Sepsis Diagnostics Market – Middle East and Africa Analysis

10.1 Overview

10.2 Middle East and Africa
  • 10.2.1 Middle East & Africa Sepsis Diagnostics Market Breakdown, by Key Country, 2022 and 2028 (%)
  • 10.2.1.1 Middle East & Africa Sepsis Diagnostics Market – Revenue and Forecast Analysis – by Country
  • 10.2.1.1 South Africa: Middle East & Africa Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.1.1 South Africa: Middle East & Africa Sepsis Diagnostics Market Breakdown, by Product
    • 10.2.1.1.2 South Africa: Middle East & Africa Sepsis Diagnostics Market Breakdown, by Technology
    • 10.2.1.1.3 South Africa: Middle East & Africa Sepsis Diagnostics Market Breakdown, by Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, Microbiology)
    • 10.2.1.1.4 South Africa: Middle East & Africa Sepsis Diagnostics Market Breakdown, by Method
  • 10.2.1.2 Saudi Arabia: Middle East & Africa Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.2.1 Saudi Arabia: Middle East & Africa Sepsis Diagnostics Market Breakdown, by Product
    • 10.2.1.2.2 Saudi Arabia: Middle East & Africa Sepsis Diagnostics Market Breakdown, by Technology
    • 10.2.1.2.3 Saudi Arabia: Middle East & Africa Sepsis Diagnostics Market Breakdown, by Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, Microbiology)
    • 10.2.1.2.4 Saudi Arabia: Middle East & Africa Sepsis Diagnostics Market Breakdown, by Method
  • 10.2.1.3 UAE: Middle East & Africa Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.3.1 UAE: Middle East & Africa Sepsis Diagnostics Market Breakdown, by Product
    • 10.2.1.3.2 UAE: Middle East & Africa Sepsis Diagnostics Market Breakdown, by Technology
    • 10.2.1.3.3 UAE: Middle East & Africa Sepsis Diagnostics Market Breakdown, by Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, Microbiology)
    • 10.2.1.3.4 UAE: Middle East & Africa Sepsis Diagnostics Market Breakdown, by Method
  • 10.2.1.4 Rest of Middle East and Africa: Middle East & Africa Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.4.1 Rest of Middle East and Africa: Middle East & Africa Sepsis Diagnostics Market Breakdown, by Product
    • 10.2.1.4.2 Rest of Middle East and Africa: Middle East & Africa Sepsis Diagnostics Market Breakdown, by Technology
    • 10.2.1.4.3 Rest of Middle East and Africa: Middle East & Africa Sepsis Diagnostics Market Breakdown, by Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, Microbiology)
    • 10.2.1.4.4 Rest of Middle East and Africa: Middle East & Africa Sepsis Diagnostics Market Breakdown, by Method

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments

13. Company Profiles

13.1 Abbott
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 BD
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 bioMerieux SA
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Danaher (Beckman Coulter)
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 F. HOFFMANN-LA ROCHE LTD.
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 T2 Biosystems, Inc.
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 THERMO FISHER SCIENTIFIC INC.
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments

14. Appendix

14.1 About Business Market Insights
14.2 List of Abbreviations

The List of Companies - Middle East & Africa Sepsis Diagnostics Market

  • Abbott
  • BD
  • bioMerieux SA
  • Danaher (Beckman Coulter)
  • F. HOFFMANN-LA ROCHE LTD.
  • T2 Biosystems, Inc.
  • THERMO FISHER SCIENTIFIC INC.

    • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)